journal article·2025-08Open access

Fabricating Microfluidic Co‐Cultures of Immortalized Cell Lines Uncovers Robust Design Principles for the Simultaneous Formation of Patterned, Vascularized, and Stem Cell‐Derived Adipose Tissue

Ashley R. Murphy, Rose Ann Franco, Mark C. Allenby

Small· Volume 21· Issue 32

Abstract

Abstract In vitro co‐culture processes supporting simultaneous formation of vessel networks alongside differentiation toward mature parenchymal tissue have numerous clinical and agricultural applications but remain unrealized due to contrasting culture requirements. Of specific interest is lab‐grown vascularized adipose tissue to study diabetes, obesity, metabolic syndrome, and cardiovascular diseases, and to advance cultivated meat technologies. A microfluidic 3D hydrogel culture device capable of supporting live‐imaging of fluorescent reporter cell lines and generating counter‐current gradients of vasculogenic and adipogenic growth factors is reported. For the first time, experimental conditions capable of reproducibly forming diverse microvascular networks from telomerase immortalized endothelial and mesenchymal stem cells in both 2D and 3D hydrogel‐embedded cultures are reported. This novel microfluidic culture design demonstrates the generation of growth factor environments which support the 3D co‐formation of integrated robust microvascular networks and lipid‐producing adipocytes after 31‐days gradient culture. Microvascular networks substantially support parenchymal stromal cell differentiation to mature adipose tissue (67.4% lipid coverage), unachieved in avascular cultures (1.86% lipid coverage). It is attempted to validate the co‐culture model by applying inhibitors of vessel‐mediated lipogenesis (spermidine and VO‐OHpic), which are demonstrated to be ineffective in this novel human preclinical model.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Engineering Faculty of Engineering Architecture and Information Technology The University of Queensland St Lucia 4072 Australia

Funding

Ramaciotti Foundations · Australian Research Council · Advance Queensland

References (85)

Show source-provided references
1. Ajmal L. · Cureus · 2023 · 15
2. 10.5661/bger-26-16310.5661/bger-26-163 ↗
3. 10.3389/fcvm.2022.88292310.3389/fcvm.2022.882923 ↗
4. 10.1038/s42255-022-00544-610.1038/s42255-022-00544-6 ↗
5. 10.1091/mbc.e06-08-069310.1091/mbc.e06-08-0693 ↗
6. 10.1016/j.jhep.2024.02.03210.1016/j.jhep.2024.02.032 ↗
7. 10.1038/nature1704010.1038/nature17040 ↗
8. 10.1002/term.293210.1002/term.2932 ↗
9. 10.3389/fmolb.2020.0003310.3389/fmolb.2020.00033 ↗
10. 10.3389/fbioe.2020.0091110.3389/fbioe.2020.00911 ↗
11. 10.3389/fphar.2018.0000610.3389/fphar.2018.00006 ↗
12. 10.1002/elps.20100013710.1002/elps.201000137 ↗
13. 10.1016/j.actbio.2023.09.01910.1016/j.actbio.2023.09.019 ↗
14. 10.1016/j.mce.2012.06.01410.1016/j.mce.2012.06.014 ↗
15. 10.1146/annurev-physiol-031620-09544610.1146/annurev-physiol-031620-095446 ↗
16. 10.1152/ajpcell.00519.202010.1152/ajpcell.00519.2020 ↗
17. 10.1111/obr.1340310.1111/obr.13403 ↗
18. 10.1002/adhm.20220144010.1002/adhm.202201440 ↗
19. 10.3389/fcvm.2021.65021410.3389/fcvm.2021.650214 ↗
20. 10.1016/j.bbadis.2013.06.00310.1016/j.bbadis.2013.06.003 ↗
21. 10.1146/annurev-physiol-042222-02134610.1146/annurev-physiol-042222-021346 ↗
22. 10.1007/s40200-020-00523-210.1007/s40200-020-00523-2 ↗
23. 10.1093/intbio/zyaa00610.1093/intbio/zyaa006 ↗
24. 10.1016/j.biomaterials.2010.01.11110.1016/j.biomaterials.2010.01.111 ↗
25. 10.1002/smtd.20220014310.1002/smtd.202200143 ↗
26. 10.1039/c3lc41320a10.1039/c3lc41320a ↗
27. 10.1016/j.biomaterials.2018.07.01410.1016/j.biomaterials.2018.07.014 ↗
28. 10.1111/odi.1403010.1111/odi.14030 ↗
29. 10.1016/j.mvr.2015.04.00610.1016/j.mvr.2015.04.006 ↗
30. 10.1369/jhc.4A6514.200510.1369/jhc.4A6514.2005 ↗
31. 10.1016/j.devcel.2011.07.00110.1016/j.devcel.2011.07.001 ↗
32. 10.1186/s13287-016-0359-310.1186/s13287-016-0359-3 ↗
33. 10.1007/s12032-022-01810-z10.1007/s12032-022-01810-z ↗
34. 10.3892/etm.2021.1032310.3892/etm.2021.10323 ↗
35. 10.1038/s41596-021-00635-w10.1038/s41596-021-00635-w ↗
36. 10.1002/jbm.a.3575410.1002/jbm.a.35754 ↗
37. Chen R. · Mol Cell Biomech · 2017 · 14 · 153
38. 10.1016/j.biomaterials.2021.12103210.1016/j.biomaterials.2021.121032 ↗
39. Khaki M. · Rep Biochem Mol Biol · 2018 · 6 · 144
40. 10.1073/pnas.16234979910.1073/pnas.162349799 ↗
41. 10.1016/j.ab.2021.11426810.1016/j.ab.2021.114268 ↗
42. 10.1038/s41574-022-00695-210.1038/s41574-022-00695-2 ↗
43. 10.1038/s42255-022-00541-910.1038/s42255-022-00541-9 ↗
44. 10.3390/molecules2302028510.3390/molecules23020285 ↗
45. 10.1007/s12154-010-0041-710.1007/s12154-010-0041-7 ↗
46. 10.1093/gerona/glab14510.1093/gerona/glab145 ↗
47. 10.1016/j.jnutbio.2024.10956910.1016/j.jnutbio.2024.109569 ↗
48. 10.1111/j.1467-789X.2009.00623.x10.1111/j.1467-789X.2009.00623.x ↗
49. 10.1038/s41598-019-47719-y10.1038/s41598-019-47719-y ↗
50. 10.1016/j.bios.2014.07.02910.1016/j.bios.2014.07.029 ↗
51. 10.1016/j.biomaterials.2021.12077610.1016/j.biomaterials.2021.120776 ↗
52. 10.1371/journal.pone.000579810.1371/journal.pone.0005798 ↗
53. 10.1038/s41598-019-41985-610.1038/s41598-019-41985-6 ↗
54. 10.1371/journal.pone.002738510.1371/journal.pone.0027385 ↗
55. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
56. 10.1038/s41577-019-0131-x10.1038/s41577-019-0131-x ↗
57. 10.1089/ten.tea.2021.002810.1089/ten.tea.2021.0028 ↗
58. American Type Culture Collection. A Chemically‐induced Method of Adipogenesis2024[Available from https://www.atcc.org/resources/technical‐documents/chemically‐induced‐method‐of‐adipogenesis.
59. 10.1016/j.actbio.2016.09.04410.1016/j.actbio.2016.09.044 ↗
60. Rossant C. · 2018
61. 10.1161/CIRCULATIONAHA.108.82360910.1161/CIRCULATIONAHA.108.823609 ↗
62. 10.1006/jtbi.2001.237210.1006/jtbi.2001.2372 ↗
63. 10.1371/journal.pone.004821010.1371/journal.pone.0048210 ↗
64. 10.1021/bi992774210.1021/bi9927742 ↗
65. STEMCELL Technologies. Human Recombinant FGF‐acidic2024[Available from https://www.stemcell.com/products/human‐recombinant‐fgf‐acidic.html.
66. 10.3390/polym1207161210.3390/polym12071612 ↗
67. 10.1186/s12918-015-0182-y10.1186/s12918-015-0182-y ↗
68. 10.1021/acsbiomaterials.6b0003110.1021/acsbiomaterials.6b00031 ↗
69. STEMCELL Technologies. Human Recombinant EGF 2024[Available from https://www.stemcell.com/products/human‐recombinant‐egf.html.
70. 10.1152/jn.00352.200410.1152/jn.00352.2004 ↗
71. 10.1039/C8IB00048D10.1039/C8IB00048D ↗
72. 10.1038/s41598-021-89229-w10.1038/s41598-021-89229-w ↗
73. 10.1023/B:ABME.0000030231.88326.7810.1023/B:ABME.0000030231.88326.78 ↗
74. STEMCELL Technologies. Human Recombinant bFGF2024[Available from https://www.stemcell.com/products/human‐recombinant‐bfgf.html.
75. 10.1529/biophysj.106.10269910.1529/biophysj.106.102699 ↗
76. 10.2174/138161282366617100211454510.2174/1381612823666171002114545 ↗
77. 10.7150/thno.368210.7150/thno.3682 ↗
78. 10.1051/mmnp/2009440410.1051/mmnp/20094404 ↗
79. Bedell W. · bioRxiv · 2019
80. 10.1186/s13036-017-0063-610.1186/s13036-017-0063-6 ↗
81. Kim J. · Int. J. Pharm. · 2008 · 353 · 205
82. 10.1007/s12020-018-1674-510.1007/s12020-018-1674-5 ↗
83. 10.2337/diab.36.8.93810.2337/diab.36.8.938 ↗
84. 10.1529/biophysj.107.10788810.1529/biophysj.107.107888 ↗
85. 10.1002/jcp.104149031110.1002/jcp.1041490311 ↗